Back to all Areas
F
Materials for Healthcare
Area F covers the full spectrum of biomaterials for healthcare applications — from biofabrication and smart bioresponsive systems to infection control, surface modification, dental and orthopedic biomaterials, polymeric and ceramic scaffolds, metals in medicine, and biobased hydrogels for tissue engineering. Nine symposia bring together materials scientists, biomedical engineers, and clinicians.
9Symposia
23Organizers
117Topics
5Days
Annabel Braem
FEMS Coordinator
Annabel Braem
KU Leuven, Belgium
Biography

Annabel Braem is associate professor in the Department of Materials Engineering at KU Leuven, affiliated with the Biomaterials and Tissue Engineering research group and the Laboratory of Complex Surfaces and Interfaces (Complexurf). Her research lies at the intersection of materials engineering and biomedical sciences, aiming to develop hybrid organic/inorganic biomaterials capable of delivering bioactive substances at implant surfaces. Her work focuses on ceramic additive manufacturing and surface modification techniques for the controlled release and immobilization of biomolecules. Over 100 papers (h-index 32). She serves as president-elect of the Belgian Ceramic Society and emeritus-chair of the American Ceramic Society Bioceramics Division.

Jürgen Stampfl
ASMET Coordinator
Jürgen Stampfl
TU Wien, Austria
Biography

Jürgen Stampfl is full professor for “Materials and Additive Manufacturing” at TU Wien since 2017, heading the research area “Polymers and Composites.” He studied applied physics at TU Graz, obtained his PhD in materials science from Montan­universität Leoben, and worked as research associate at Stanford University’s Rapid Prototyping Lab (1997–2000). His expertise lies in lithography-based additive manufacturing technologies and materials development (polymers, ceramics). He co-founded Lithoz GmbH and Cubicure GmbH, providing 3D-printing equipment and materials. Recipient of the Houska Prize (2013, 2019) and the H.F. Mark Medal (2021).

9 of 9 shown
No symposia match your search.
F1
Biofabrication and 3D Printing of Biomaterials
This symposium addresses the rapidly evolving field of biofabrication and additive manufacturing of biomaterials for biomedical applications. It covers the design, fabrication, and characterization of 3D-printed constructs using polymers, hydrogels, proteins and cells, ceramics, and composite materials. Bridging materials science, engineering, and biology, it fosters interdisciplinary collaboration spanning ink/bioink development, scaffold engineering, organ-on-chip systems, and regulatory pathways. Both fundamental research and translational applications are welcome, with emphasis on innovations enabling clinical translation of biofabricated constructs for tissue engineering, regenerative medicine, and drug delivery.
Description, Topics & Organizers
Biofabrication and 3D printing of biomaterials represent a transformative frontier in materials science and biomedical engineering. The convergence of advanced manufacturing technologies with novel biomaterial formulations has opened unprecedented opportunities for creating patient-specific implants, functional tissue constructs, and sophisticated in vitro models. This symposium provides a forum for researchers, engineers, and clinicians to present and discuss the latest advances in biofabrication technologies, including extrusion-based bioprinting, inkjet printing, stereolithography (SLA), digital light processing (DLP), laser-assisted bioprinting, and multi-material printing strategies. Special attention is given to the development of inks/bioinks and printable biomaterials. Sessions will address printability and shape fidelity, mechanical and biological performance, vascularization strategies, and scalability for clinical manufacturing.
Bioink formulation & optimisation: hydrogels, dECM, synthetic & natural polymers Extrusion-based bioprinting & FDM of biomaterials Stereolithography (SLA) & digital light processing (DLP) Inkjet & laser-assisted bioprinting technologies 3D printing of ceramic & bioceramic scaffolds Biofabrication of vascularised tissue constructs 4D printing & shape-memory biomaterials Organ-on-chip & in vitro model fabrication Patient-specific implants & prosthetics via AM Mechanical characterisation of 3D-printed constructs Cell-laden bioprinting & post-printing cell viability Drug delivery systems via additive manufacturing Computational modelling & simulation Regulatory considerations & clinical translation Sustainable & biodegradable materials for biofabrication
Tamilselvan Mohan
Tamilselvan Mohan
TU Graz, Austria
Jasper van Hoorick
Jasper van Hoorick
BioInx, Belgium
F2
Smart Biomaterials and Bioresponsive Systems
Smart biomaterials are increasingly central to modern healthcare, capable of sensing, responding, and adapting to biological environments. This class of bioresponsive materials is reshaping therapeutic, diagnostic, and regenerative strategies. The symposium highlights advances in hybrid material systems engineered for adaptive behaviour, including controlled degradation, biochemical feedback, and microenvironment-specific activation. The focus extends to stimuli-responsive drug delivery, injectable depots, nanotheranostics, and smart scaffolds with improved integration in implantable, regenerative, and diagnostic applications.
Description, Topics & Organizers
Smart biomaterials are increasingly designed to evolve structurally and functionally over time while integrating multi-modal responsiveness to chemical, mechanical, electrical, and metabolic cues. This symposium invites contributions to explore emerging strategies in smart and bioresponsive material systems. We welcome research on sensing, adaptive behaviour, controlled release, stimuli-responsive delivery, injectable depots, structurally tuneable self-assemblies, dynamic interfaces, and microenvironment-specific activation. Participation is encouraged from groups working in stimulus-responsive biomaterials, bioactive and multifunctional surfaces, soft and hybrid material systems, mechanobiology-guided design, and computational or data-driven materials development. The aim is to highlight how intelligent material design, supported by AI-assisted optimization, can drive next-generation solutions for implants, regenerative systems, drug delivery, and healthcare-relevant interfaces.
Stimulus-responsive biomaterials Adaptive degradation & time-programmed behaviour Dynamic & multifunctional biointerfaces Hybrid organic-inorganic material platforms Micro- & nanoscale sensing and actuation Multimodal, evolving bioresponsive systems AI-assisted design & high-throughput screening Biomaterials for mRNA, nucleic acid & gene delivery 3D & 4D printing of programmable biomaterials Smart biomaterials for extracellular vesicle therapies Smart biomaterials for organoids & organ-on-chip Self-healing biomaterials & wearable sensors Stimuli-responsive nanomedicines Smart hydrogels & self-assembled drug depots Bioresponsive nanotheranostics & precision nanomedicine
Anan Yaghmur
Anan Yaghmur
University of Copenhagen, Denmark
Swathi N.V. Raghu
Swathi N.V. Raghu
University of Siegen, Germany